Plain-English translation of NCT07245082 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term observation study that tracks people with type 2 diabetes to understand how the disease progresses and what factors influence complications like heart disease, kidney problems, and nerve damage. Researchers will collect information about your metabolic health, nutrition, physical strength, and lifestyle habits. The goal is to identify patterns that help doctors provide better, individualized care for people with diabetes.
Many people with type 2 diabetes develop serious complications, but doctors don't always know which patients are at highest risk or how to best prevent these complications. This study aims to fill that gap by gathering real-world information about what influences outcomes, so treatments can be tailored to each person's needs.
You likely qualify if…
You likely don't qualify if…
You would join a group of about 2,000 people with type 2 diabetes who are being followed over time. During visits, you'll have basic health measurements taken (like weight, grip strength, and body composition), answer questions about your diet and lifestyle, and have information from your medical records collected. The study combines data gathered from the past with ongoing monitoring, so researchers can track how your health changes and what factors matter most.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
Taiwan
Enrollment target
~2,000 participants
Started
October 2025
Primary completion
August 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Chia-Wen Lu, Present Professor
Department of Family Medicine, National Taiwan University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.